Can young sarcoma survivors fully recover? a new study investigates
NCT ID NCT06737172
First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time
Summary
This study looks at children, teens, and young adults who finished treatment for bone or soft tissue sarcoma in the lower leg or thigh 1 to 5 years ago. It measures muscle size, body composition, strength, mobility, and quality of life to see if they have lasting physical limitations. The goal is to understand what deficits remain after treatment and how they affect daily life, helping to support this under-researched group.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal specific long-term physical deficits in young sarcoma survivors, guiding future rehabilitation programs to improve their quality of life.
- What could go wrong
- This is a small, observational study with only 18 participants, so findings may not apply to all patients. It measures outcomes at one point in time, not over years, limiting its ability to show cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 18 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants include children and adolescents during follow-up in Munich/Germany for soft tissue sarcoma or bone tumor at the lower extremity currently 1-5 years after cessation of treatment.
- Ages
-
6 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Cessation of treatment for a bone tumor or soft tissue sarcoma of the lower extremity 1-5 years ago * Age Range of 6 to 18 years * Treatment has been conducted at one of the two designated study sites Exclusion Criteria: * Medical contraindications for testing (e.g. injury, pain, dizziness, lack of orthopedic clearance for weight-bearing in the tumor region, other acute orthopedic limitations unrelated to the underlying condition, etc.) * Language barriers that prevent understanding of the instructions for study participation * Cognitive impairment or developmental delay that hinders comprehension of the instructions in the testing situation, thereby preventing standardized diagnostic data collection
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bone sarcoma of the lower extremity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. von Haunersches Kinderspital, University of Munich
Munich, Bavaria, 80337, Germany
-
Technical University of Munich, Germany; TUM School of Medicine and Health, Department of Pediatrics. German Center for Child and Adolescent Health (DZKJ), partner site Munich
Munich, Bavaria, 80804, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.